Zydus’ manufacturing plant gets 5 U.S. FDA observations

The U.S. Food and Drug Administration (U.S. FDA) has issued five observations, post inspection, to the manufacturing plant of Zydus in Moraiya, Ahmedabad.

The inspection was conducted from October 5-13 and closed with 5 observations. The company will closely work with the U.S. FDA to address the observations expeditiously, Zydus Lifesciences said on Tuesday.